Condition
Genitourinary Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 10 Genitourinary Cancer clinical trials that are recruiting, at sites in 3 countries (most in United States (5), Canada (4), Belgium (1)). By phase: Phase 2 (3). The most active sponsors are University Health Network, Toronto (3), University of California, Irvine (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 10Clinical trials
- 3Countries
Newest Genitourinary Cancer clinical trials
All recruiting trials (10)
-
High-precision detection of leftover cancer using a liquid-biopsy platform (SHERLOCK)
This project will test whether sensitive blood and other fluid tests for circulating tumor DNA can find leftover cancer (minimal residual disease) in adults treated with curative intent for breast, lung, melanoma, gynecologic, or genitourinary cancers.
-
Riluzole to prevent thinking and memory problems during chemotherapy
This pilot trial tests whether riluzole can prevent thinking and memory problems in adults with cancer receiving anthracycline- or platinum-based chemotherapy.
-
High-resolution imaging to check if tumors are completely removed during surgery
This study is testing if high-resolution imaging during surgery can help make sure all tumors are removed in patients with different types of cancer, like breast, prostate, and thyroid, to improve their treatment outcomes.
-
Evaluating opioid use after surgery in genitourinary cancer patients
This study looks at how much pain medicine people use after surgery for genitourinary cancers and whether they are happy with their care, while also teaching them how to safely get rid of leftover medicine.
-
Using Riluzole to Help Breast Cancer Survivors with Cognitive Issues
This study is testing if the medication riluzole can help breast cancer survivors who are having trouble with thinking and memory feel better.
-
Understanding Urothelial and Rare Genitourinary Cancers
This study is trying to learn more about urothelial and rare genitourinary cancers by gathering health information and samples from adults who have been diagnosed with these cancers.
-
Using blood tests to assess early treatment response in cancer patients
This study is testing if blood tests that look for cancer DNA can help doctors see how well treatment is working for patients with different types of solid tumors.
-
Effects of Atezolizumab on Cancer Patients with Sensitive Tumor DNA or RNA
This study is testing if atezolizumab can help cancer patients with certain tumor types that show they might respond well to the treatment.
-
Investigating genetic reasons for unusual responses to cancer treatment
This study is trying to find out how genetic differences in cancer patients affect their responses to treatment, so doctors can tailor therapies to work better for each individual.
-
Collecting tumor samples to improve cancer treatment matching
This study is collecting tumor samples from patients with advanced cancer to see if analyzing their genes can help doctors find the best treatments for them.
Related topics
Quick answers
How many Genitourinary Cancer clinical trials are recruiting right now?
10, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (5 trials), Canada (4 trials), Belgium (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.